August 2026

Dymista

azelastine hydrochloride and fluticasone propionate

Mylan Specialty LP

Spray, metered (nasal) · NDA 202236

Last listed protection ended
August 24, 2026

The FDA listed 1 patent for Dymista, and this is the day the last one ended. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    Patent 8,168,620
    Claims the drug product
  2. Ended
    Patent 8,168,620
    Pediatric extension: six more months